Biomedical Entrepreneurship Skills Development Program for the Advancement of Research Translation
促进研究转化的生物医学创业技能发展计划
基本信息
- 批准号:10462522
- 负责人:
- 金额:$ 10.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-12 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Applications GrantsAreaAttitudeAutoimmunityBedsBiological SciencesBiomedical TechnologyBusinessesCase StudyClinical and Translational Science AwardsCommunitiesComplexConsultationsCourse ContentDevelopmentDiabetes MellitusDiseaseDissemination and ImplementationEducationEducational CurriculumEducational ModelsEducational workshopEffectivenessEntrepreneurshipEvaluationFacultyFundingGoalsGoldGrantHealthHealthcareIndividualIndustryInflammatoryKidney DiseasesKnowledgeKnowledge acquisitionLearningLearning SkillLegal patentMalignant NeoplasmsMeasuresMedical DeviceMedicineMentorsMetabolic DiseasesMethodologyMethodsMissionModelingModificationMolecularMonitorMotivationNational Institute of Diabetes and Digestive and Kidney DiseasesNew York CityObesityOutcomePaperParticipantPathogenesisPathway interactionsPatientsPostdoctoral FellowProcessProgram DevelopmentReach Effectiveness Adoption Implementation and MaintenanceResearchResearch PersonnelRunningScienceScientistSeriesSoftware ToolsSutentTalentsTherapeuticTranslational ResearchTranslationsUnited States National Institutes of HealthWorkbasecareercareer developmentcommercializationcourse implementationcourse introductioncurriculum developmentdesigndoctoral studentdrug developmentfallsformative assessmentimprovedinfliximabinnovationinterestinventionlearning materialslecturesmembernovelprogramsproject-based learningskill acquisitionskillsstudent trainingsuccess
项目摘要
Abstract:
This grant proposal describes a plan to design, implement and integrate within the NYU community an
educational program that teaches and trains students in Biomedical Entrepreneurship, with focus on the
commercialization of academic discoveries and inventions. The program builds upon the success of the
recently funded drug development educational program (NIDDK R25DK092170), developed and directed by
Drs. Gold-von Simson and Ramasamy, and aims to further expand the skill set of early stage scientists to
prepare them to actively participate in bed to bedside science translation. Through a variety of methods,
participants will gain an understanding of the requirements for launching and building a new venture in the
complex and highly regulated life sciences industry as well as the entrepreneurial journey of the scientist-
entrepreneur.
The program will focus on improving health innovations and developing effective solutions; this is at the core of
our mentored, entrepreneurial process. We will build upon the academic excellence at NYU with its track
record of success; two examples of successful collaborative discoveries at NYU led to the development of
disease altering therapies like Infliximab (Remicade) and Sunitinib (Sutent). Our program aims to promote
the commercial development of novel discoveries and breakthroughs, while leveraging early stage researchers
with innovative and creative ideas. The goal is to teach scientists and likeminded individuals at an early career
stage how to create solutions, whether at the molecular level or via the creation of medical devices or software
tools, to benefit those who suffer from disease. By introducing participants to the similarities and connections
between the pathogenesis mechanisms underlying diabetes and many metabolic diseases, and certain other
disease areas, we will enable and encourage them to think creatively about potential applications for their own
research from seemingly unrelated disease contexts such as autoimmunity and hyperimmunity, cancer, necro-
inflammatory diseases and others ultimately advancing the goals of the NIDDK and the NIH as a whole.
With the support of NIDDK, we can build a successful and self-sustaining biomedical entrepreneurship
educational program within the NYU and New York City community and provide career development support to
talented young scientists. With success of our program, we will share the curricula and methods with other US
academic centers, resulting in a positive and expeditious effect on the translation of science and medicine
nationally, a great mission of NIH.
抽象的:
该拨款提案描述了一项在纽约大学社区内设计、实施和整合的计划
教授和培训学生生物医学创业的教育计划,重点关注
学术发现和发明的商业化。该计划建立在
最近资助的药物开发教育计划(NIDDK R25DK092170),由
博士。 Gold-von Simson 和 Ramasamy,旨在进一步扩展早期科学家的技能
准备他们积极参与床边科学转化。通过多种方式,
参与者将了解在该地区启动和建立新企业的要求
复杂且监管严格的生命科学行业以及科学家的创业之旅——
企业家。
该计划将重点关注改善健康创新和开发有效的解决方案;这是核心
我们的指导创业过程。我们将在纽约大学的学术卓越基础上建立其轨道
成功记录;纽约大学成功合作发现的两个例子导致了
疾病改变疗法,如英夫利昔单抗 (Remicade) 和舒尼替尼 (Sutent)。我们的计划旨在促进
新发现和突破的商业开发,同时利用早期研究人员
具有创新和创意的想法。目标是在早期职业生涯中教授科学家和志同道合的人
阶段如何创建解决方案,无论是在分子水平还是通过创建医疗设备或软件
工具,造福那些患有疾病的人。通过向参与者介绍相似之处和联系
糖尿病和许多代谢性疾病以及某些其他疾病的发病机制之间的关系
疾病领域,我们将帮助并鼓励他们创造性地思考自己的潜在应用
来自看似无关的疾病背景的研究,例如自身免疫和超免疫、癌症、坏死性
炎症性疾病和其他疾病最终推进 NIDDK 和 NIH 的整体目标。
在NIDDK的支持下,我们可以建立一个成功的、自我维持的生物医药创业企业
纽约大学和纽约市社区内的教育计划,并为以下人员提供职业发展支持
有才华的年轻科学家。随着我们项目的成功,我们将与美国其他国家分享课程和方法
学术中心,对科学和医学的翻译产生积极而迅速的影响
在全国范围内,这是 NIH 的一项伟大使命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gabrielle Gold-von Simson其他文献
Gabrielle Gold-von Simson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gabrielle Gold-von Simson', 18)}}的其他基金
Biomedical Entrepreneurship Skills Development Program for the Advancement of Research Translation
促进研究转化的生物医学创业技能发展计划
- 批准号:
10223282 - 财政年份:2019
- 资助金额:
$ 10.2万 - 项目类别:
Biomedical Entrepreneurship Skills Development Program for the Advancement of Research Translation
促进研究转化的生物医学创业技能发展计划
- 批准号:
10673975 - 财政年份:2019
- 资助金额:
$ 10.2万 - 项目类别:
A New Era of Targeted Drug Discovery and the Path of Development: From Molecular
靶向药物发现的新时代及发展路径:从分子开始
- 批准号:
9081581 - 财政年份:2012
- 资助金额:
$ 10.2万 - 项目类别:
A New Era of Targeted Drug Discovery and the Path of Development: From Molecular
靶向药物发现的新时代及发展路径:从分子开始
- 批准号:
8487400 - 财政年份:2012
- 资助金额:
$ 10.2万 - 项目类别:
A New Era of Targeted Drug Discovery and the Path of Development: From Molecular
靶向药物发现的新时代及发展路径:从分子开始
- 批准号:
8335603 - 财政年份:2012
- 资助金额:
$ 10.2万 - 项目类别:
A New Era of Targeted Drug Discovery and the Path of Development: From Molecular
靶向药物发现的新时代及发展路径:从分子开始
- 批准号:
8728202 - 财政年份:2012
- 资助金额:
$ 10.2万 - 项目类别:
A New Era of Targeted Drug Discovery and the Path of Development: From Molecular
靶向药物发现的新时代及发展路径:从分子开始
- 批准号:
8874211 - 财政年份:2012
- 资助金额:
$ 10.2万 - 项目类别:
相似国自然基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
- 批准号:2021JJ40433
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
- 批准号:32001603
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
AREA国际经济模型的移植.改进和应用
- 批准号:18870435
- 批准年份:1988
- 资助金额:2.0 万元
- 项目类别:面上项目
相似海外基金
Onboarding Rural Area Mathematics and Physical Science Scholars
农村地区数学和物理科学学者的入职
- 批准号:
2322614 - 财政年份:2024
- 资助金额:
$ 10.2万 - 项目类别:
Standard Grant
Point-scanning confocal with area detector
点扫描共焦与区域检测器
- 批准号:
534092360 - 财政年份:2024
- 资助金额:
$ 10.2万 - 项目类别:
Major Research Instrumentation
TRACK-UK: Synthesized Census and Small Area Statistics for Transport and Energy
TRACK-UK:交通和能源综合人口普查和小区域统计
- 批准号:
ES/Z50290X/1 - 财政年份:2024
- 资助金额:
$ 10.2万 - 项目类别:
Research Grant
Wide-area low-cost sustainable ocean temperature and velocity structure extraction using distributed fibre optic sensing within legacy seafloor cables
使用传统海底电缆中的分布式光纤传感进行广域低成本可持续海洋温度和速度结构提取
- 批准号:
NE/Y003365/1 - 财政年份:2024
- 资助金额:
$ 10.2万 - 项目类别:
Research Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326714 - 财政年份:2024
- 资助金额:
$ 10.2万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427233 - 财政年份:2024
- 资助金额:
$ 10.2万 - 项目类别:
Standard Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326713 - 财政年份:2024
- 资助金额:
$ 10.2万 - 项目类别:
Standard Grant
Unlicensed Low-Power Wide Area Networks for Location-based Services
用于基于位置的服务的免许可低功耗广域网
- 批准号:
24K20765 - 财政年份:2024
- 资助金额:
$ 10.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427232 - 财政年份:2024
- 资助金额:
$ 10.2万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427231 - 财政年份:2024
- 资助金额:
$ 10.2万 - 项目类别:
Standard Grant














{{item.name}}会员




